Euroapi S.A. (EAPIF)
OTCMKTS · Delayed Price · Currency is USD
3.650
0.00 (0.00%)
At close: Jul 15, 2025

Euroapi Company Description

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.

The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry; particle engineering; microbial fermentation; small molecules synthesis; prostaglandins; steroids and hormones; and opiates and controlled substances.

It provides their products to pharmaceutical, generic drug manufacturers, animal health product manufacturers, consumer health, nutrition and cosmetic product companies, biotech companies, and distribution companies, as well as contract development and manufacturing organization.

Euroapi S.A. was incorporated in 2020 and is based in Paris, France.

Euroapi S.A.
CountryFrance
Founded2020
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees3,187
CEODavid Seignolle

Contact Details

Address:
15 Rue Traversiere
Paris, 75012
France
Phone33 1 89 20 62 00
Websiteeuroapi.com

Stock Details

Ticker SymbolEAPIF
ExchangeOTCMKTS
Fiscal YearJanuary - December
Reporting CurrencyEUR
ISIN NumberFR0014008VX5
SIC Code2833

Key Executives

NamePosition
David SeignolleChief Executive Officer
Olivier FalutChief Financial Officer
Sophie PalliezHead of Investor Relations
Marion SantinChief Legal, Compliance, and IP Officer
Elizabeth EhringerChief People Officer
Vincent TourailleChief Strategy and M&A Officer
Frederic LelievreChief Quality Officer
Emmanuel MazeaudChief Digital Officer
Laurence BollackHead of Global Media Relations
Thierry DurandChief Research and Development Officer